Skip to main content

Glenn Boehnlein

Board Member

Inogen Inc (INGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Inogen Inc publishes a filing, an earnings call transcript or a press release.

Get INGN alerts

About Glenn Boehnlein

Glenn Boehnlein is recorded as Board Member at Inogen Inc (INGN) since June 5, 2026. Earlier roles on record: CFO and CEO at Stryker Corp (SYK) until April 1, 2025. Inogen Inc reported in an 8-K filed June 11, 2026 that Glenn Boehnlein was appointed Class III Director, effective June 5, 2026. Stryker Corp reported in an 8-K filed January 28, 2025 that Glenn Boehnlein retired as Vice President, Chief Financial Officer, effective April 1, 2025. Inogen Inc reported in an 8-K filed June 6, 2023 that Glenn Boehnlein was appointed Class III director, effective May 31, 2023. The proxy statement of Stryker Corp reports total compensation of $1,893,046 for Glenn Boehnlein in fiscal 2025, including a base salary of $800,000. Disclosed compensation is on record for 9 fiscal years. Glenn Boehnlein has spoken on 20 earnings calls across 1 company, most recently for Stryker Corp on January 28, 2025. Inogen Inc is classified in the Medical Devices industry within the Healthcare sector. Other companies whose calls Glenn Boehnlein spoke on are classified in the Healthcare sector. Other leadership on record at Inogen Inc includes Andrew (“Andy”) P. Reding (CEO and Board Member), Elizabeth Mora (Chairman and Board Member), Jason Richardson (CFO) and 7 others.

“The following nominees were elected to serve as Class III directors, to hold office until the Company's 2029 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified:”
Inogen Inc Form 8-K, filed June 11, 2026 · Read the filing
“Glenn S. Boehnlein has decided to retire from his role as Vice President, Chief Financial Officer of the Company effective April 1, 2025”
Stryker Corp Form 8-K, filed January 28, 2025 · Read the filing

Glenn Boehnlein on recent calls

“Today, I will focus my comments on our fourth-quarter financial results and the related drivers. Our detailed financial results have been provided in today's press release.”
CFO, Stryker Corp Q4 FY2024 Earnings Call ·
“Today I will focus my comments on our third quarter financial results and the related drivers. Our detailed financial results have been provided in today's press release.”
CFO, Stryker Corp Q3 FY2024 Earnings Call ·
“Today I will focus my comments on our second quarter financial results and the related drivers. Our detailed financial results have been provided in today's press release.”
CFO, Stryker Corp Q2 FY2024 Earnings Call ·
“Today, I will focus my comments on our first quarter financial results and the related drivers. Our detailed financial results have been provided in today's press release.”
CFO, Stryker Corp Q1 FY2024 Earnings Call ·
“Today, I will focus my comments on our fourth quarter financial results and the related drivers. Our detailed financial results have been provided in today's press release.”
CFO, Stryker Corp Q4 FY2023 Earnings Call ·

Affiliation history

Company network

Current role

Medical Devices · Healthcare

Board Member

2026-06-05–present

Leadership on record at Inogen Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Stryker Corp (SYK) $800,000 $1,893,046
2024 Stryker Corp (SYK) $793,334 $7,339,754
2023 Stryker Corp (SYK) $755,834 $6,841,484
2022 Stryker Corp (SYK) $730,833 $5,853,281
2021 Stryker Corp (SYK) $705,000 $6,015,333
2020 Stryker Corp (SYK) $634,167 $4,345,853
2019 Stryker Corp (SYK) $650,000 $4,375,730
2018 Stryker Corp (SYK) $595,000 $3,788,573
2017 Stryker Corp (SYK) $577,628 $3,141,202

Recent activity

Show 11 earlier activities